Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ReShape Medical Inc.

pro.reshapeready.com

Latest From ReShape Medical Inc.

Thirty-five Years Covering Health Care: The More Things Change…

The health care industry has come a long way in the past 35 years, although in some areas very little has changed. Recently retired In Vivo editor Peter Charlish has seen most of the major developments, and in his final feature, he looks back at some of the big stories in a reporting career that began in the early 1980s.

BioPharmaceutical Medical Device

Obesity Firm Allurion Preps For Global Expansion, US Trial With Changes At Top

Intragastric balloon-maker Allurion is making some major changes in its executive suite to support its plan to expand its market reach.

Clinical Trials Business Strategies

Deals Shaping The Medical Industry, November 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2017.

Deals BioPharmaceutical

Bariatric Devices: Intragastric Balloons To Eclipse Gastric Banding

The market for minimally invasive weight loss devices will reach more than $290 million by 2021, according to a new report from Informa’s Meddevicetracker. Issues relating to laparoscopic adjustable gastric banding systems will result in a greater emphasis being placed on intragastric balloons, which will grow at twice the segment average.

Medical Device Metabolic
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ReShape Medical Inc.
  • Senior Management
  • Michael Mangano, Pres. & CEO
    John Lehmann, MD, CMO
    Bob Haggerty, VP, Sales
    Amy Scott, VP, Mktg.
  • Contact Info
  • ReShape Medical Inc.
    Phone: (844) 937-7374
    236 Avenida Fabricante
    Ste. 201
    San Clemente, CA 92672
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register